Wildon Farwell
Chief Tech/Sci/R&D Officer at DYNE THERAPEUTICS, INC.
Net worth: 4 M $ as of 30/03/2024
Profile
Wildon R. Farwell is Chief Medical Officer of Dyne Therapeutics, Inc. Dr. Farwell previously occupied the position of Global Medical Head-Medical Diseases at Biogen, Inc. Dr. Farwell received a doctorate from the University of Missouri School of Medicine and a graduate degree from Harvard T.H. Chan School of Public Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
DYNE THERAPEUTICS INC
0.19% | 11/03/2024 | 150,560 ( 0.19% ) | 4 M $ | 30/03/2024 |
Wildon Farwell active positions
| Companies | Position | Start |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 03/03/2021 |
Former positions of Wildon Farwell
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Chief Tech/Sci/R&D Officer | 28/02/2021 |
| Harvard Medical School | Corporate Officer/Principal | - |
Training of Wildon Farwell
| Harvard T.H. Chan School of Public Health | Graduate Degree |
| University of Missouri School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| DYNE THERAPEUTICS, INC. | Health Technology |
- Stock Market
- Insiders
- Wildon Farwell
